Indian Fluticasone Exporters: Complete Supplier Ranking with Market Share — 664 Manufacturers (2026) — TransData Nexus

Q: Who is the largest fluticasone buyer importing from India?

MYLAN IRELAND LTD (NETHERLANDS) is the largest fluticasone importer from India with a 24.6% market share and import value of $50.0M.

Q: How many fluticasone buyers import from India?

There are 664 active fluticasone buyers importing from India, with a combined import market of $203.0M across 9,009 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top fluticasone buyers from India?

The top 5 fluticasone buyers — MYLAN IRELAND LTD, MYLAN IRELAND LIMITED, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR, APOTEX INC, CIPLA USA INC UPS SUPPLY CHAIN SOLU — together control 43.8% of total fluticasone import value from India.

Suresh Sormare

Fluticasone

India Pharmaceutical Trade Intelligence

$203.0M239 Suppliers123 CountriesHS 30049099

ExportsIndia → NETHERLANDS34.2%India → AUSTRALIA10.1%

ImportsUNITED KINGDOM → India$2.6B UNITED STATES → India$54.3M

#1 Supplier: CIPLA LIMITED

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

Netherlands emerges as the first largest importing country, achieving a total trade value of $69.4M through 485 shipments. This represents a market share of 34.2% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Netherlands has a diverse importer base, with their top importers including:

• MYLAN IRELAND LTD - $50.0M (72.0% of country's total business)

• MYLAN IRELAND LIMITED - $16.9M (24.3% of country's total business)

Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $143.1K, indicating premium pricing strategy compared to the market average of $22.5K.

Netherlands is a key market for Fluticasone imports, representing 34.2% of total trade value.

Primary Market

Secondary Market

2Australia

Australia emerges as the second largest importing country, achieving a total trade value of $20.4M through 99 shipments. This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Fluticasone buyer market intelligence

1Buyer Segment Analysis

The 664 buyers of Fluticasone from India can be categorized into several segments:

1. Pharmaceutical Companies: Entities like MYLAN IRELAND LTD and APOTEX INC are pharmaceutical manufacturers that procure Fluticasone as an active pharmaceutical ingredient (API) for their formulations. Their purchasing patterns typically involve large, consistent orders to meet production demands.

2. Distributors: Companies such as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR in Turkey act as intermediaries, purchasing Fluticasone in bulk and supplying it to various healthcare providers. Their orders are substantial and regular, aligning with market demand.

3. Contract Manufacturers: Entities like CIPLA USA INC UPS SUPPLY CHAIN SOLU procure Fluticasone to manufacture products on behalf of other companies. Their purchasing behavior is project-based, with volumes varying according to contractual obligations.

4. Re-exporters: Companies such as MYLAN AUSTRALIA and VIATRIS PTY LTD in Australia may import Fluticasone for re-export to other markets. Their order sizes and frequencies depend on the demand in their target export destinations.

Each segment's procurement strategies are influenced by factors such as regulatory requirements, market demand, and supply chain logistics.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Fluticasone buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Fluticasone are as follows:

1. Netherlands:

Regulatory Authority: Medicines Evaluation Board (MEB).

Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.

Estimated Timeline: Approximately 210 days.

Import Tariff/Duty: Medicaments under HS Code 30049099 are subject to a 0% import duty.

2. Australia:

Regulatory Authority: Therapeutic Goods Administration (TGA).

Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of comprehensive product data.

Demand Drivers & Market Opportunity

TransData Nexus Fluticasone buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Fluticasone in importing countries is driven by several factors:

1. Disease Prevalence: Fluticasone is primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). According to the World Health Organization (WHO), as of 2025, approximately 262 million people worldwide suffer from asthma, and 212 million from COPD, indicating a substantial patient base requiring inhaled corticosteroids like Fluticasone.

2. Government Healthcare Programs: Many countries have implemented programs to improve access to essential medicines. For instance, the WHO's Model List of Essential Medicines includes Fluticasone, encouraging its procurement and distribution in member countries.

3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential respiratory medicines in their formularies, increasing demand for Fluticasone.

4. Tender-Based Purchasing: Public sector procurement through competitive tendering processes ensures the availability of cost-effective medicines. The WHO recommends tendering as a method to improve affordability and availability of essential medicines.

With 664 buyers across 123 countries, the global reach and consistent demand for Fluticasone underscore its critical role in respiratory disease management and present significant market opportunities for suppliers.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Fluticasone Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest fluticasone buyer importing from India?

Based on import volume and value, MYLAN IRELAND LTD (NETHERLANDS) leads with $50.0M in imports and a 24.6% market share — the highest of any single fluticasone importer. MYLAN IRELAND LIMITED (NETHERLANDS) and PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR (TURKEY) are the next largest buyers.

QHow many companies buy fluticasone from India?

There are 664 active fluticasone buyers importing from India, with a combined market of $203.0M across 9,009 shipments to 123 countries. The top 5 buyers hold 43.8% of total import value, while the remaining 659 buyers handle the other 56.2%.

QWhich countries import the most fluticasone from India?

The top importing countries for fluticasone from India are Netherlands (34.2%), Australia (10.1%), Canada (5.9%), South Africa (5.4%), Turkey (4.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of fluticasone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for fluticasone from India?

The average import transaction value for fluticasone from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Fluticasone buyer market intelligence

1Buyer Segment Analysis

The 664 buyers of Fluticasone from India can be categorized into several segments:

Each segment's procurement strategies are influenced by factors such as regulatory requirements, market demand, and supply chain logistics.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Fluticasone buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Fluticasone are as follows:

1. Netherlands:

Regulatory Authority: Medicines Evaluation Board (MEB).

Import Registration Process: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.

Estimated Timeline: Approximately 210 days.

Import Tariff/Duty: Medicaments under HS Code 30049099 are subject to a 0% import duty.

2. Australia:

Regulatory Authority: Therapeutic Goods Administration (TGA).

Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of comprehensive product data.

Demand Drivers & Market Opportunity

TransData Nexus Fluticasone buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Fluticasone in importing countries is driven by several factors:

3. Universal Health Coverage Expansion: Countries expanding their universal health coverage often include essential respiratory medicines in their formularies, increasing demand for Fluticasone.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fluticasone

Fluticasone

Who Buys Fluticasone from India — 664 Importers Behind a $203.0M Market

Top Fluticasone Importers — Ranked by Import Value

Top Fluticasone Buyers & Importers

Related Analysis

Need Details?

Fluticasone — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Fluticasone — and from which countries?

Fluticasone — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

2Australia

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Fluticasone Buyers & Importers

QWho is the largest fluticasone buyer importing from India?

QHow many companies buy fluticasone from India?

QWhich countries import the most fluticasone from India?

QWhat is the average import order value for fluticasone from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Canada

4South Africa

5Turkey

Analysis Methodology